These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification. Kalyan K, Basu D, Soundararaghavan J. Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715 [Abstract] [Full Text] [Related]
8. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large-cell lymphomas of T-cell origin. A clinicopathologic and immunohistochemical study in 20 patients. Beljaards RC, Meijer CJ, Scheffer E, Toonstra J, van Vloten WA, van der Putte SC, Geerts ML, Willemze R. Am J Pathol; 1989 Dec; 135(6):1169-78. PubMed ID: 2556926 [Abstract] [Full Text] [Related]
9. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases]. Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y. Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665 [Abstract] [Full Text] [Related]
10. Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54). Horst E, Meijer CJ, Radaszkiewicz T, Ossekoppele GJ, Van Krieken JH, Pals ST. Leukemia; 1990 Aug; 4(8):595-9. PubMed ID: 1974938 [Abstract] [Full Text] [Related]
11. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma. Dreyling MH, Roulston D, Bohlander SK, Vardiman J, Olopade OI. Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637 [Abstract] [Full Text] [Related]
13. T-cell and T/natural killer-cell lymphomas involving ocular and ocular adnexal tissues: a clinicopathologic, immunohistochemical, and molecular study of seven cases. Coupland SE, Foss HD, Assaf C, Auw-Haedrich C, Anastassiou G, Anagnostopoulos I, Hummel M, Karesh JW, Lee WR, Stein H. Ophthalmology; 1999 Nov; 106(11):2109-20. PubMed ID: 10571346 [Abstract] [Full Text] [Related]
14. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage]. Zou GR, Zhang YJ, Xie FY, Zheng W, Li HX, Xia YF, Lin TY, Lu TX. Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383 [Abstract] [Full Text] [Related]
15. Systemic anaplastic large-cell lymphoma: results from the non-Hodgkin's lymphoma classification project. Weisenburger DD, Anderson JR, Diebold J, Gascoyne RD, MacLennan KA, Müller-Hermelink HK, Nathwani BN, Ullrich F, Armitage JO. Am J Hematol; 2001 Jul; 67(3):172-8. PubMed ID: 11391714 [Abstract] [Full Text] [Related]
16. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity. Takahashi H, Fujita S, Okabe H, Tsuda N, Tezuka F. Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573 [Abstract] [Full Text] [Related]
18. [Clinical significance of immunophenotype in diffuse non-Hodgkin's lymphoma: with special emphasis on the clinical characteristics of T-cell lymphoma]. Chubachi A, Miura AB, Takatsu H, Yamaguchi A, Nishimura S, Nakayama Y, Akihama T, Miura S, Saitoh M, Watanuki T. Gan To Kagaku Ryoho; 1991 Jul; 18(8):1303-9. PubMed ID: 2069401 [Abstract] [Full Text] [Related]